Product Code: ETC7746494 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Preclinical CRO Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Preclinical CRO Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Preclinical CRO Market - Industry Life Cycle |
3.4 Japan Preclinical CRO Market - Porter's Five Forces |
3.5 Japan Preclinical CRO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 Japan Preclinical CRO Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Japan Preclinical CRO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for outsourcing preclinical research activities to specialized CROs for cost efficiency and expertise. |
4.2.2 Growing focus on drug development and research by pharmaceutical and biotechnology companies in Japan. |
4.2.3 Technological advancements in preclinical research leading to the need for specialized services from CROs. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and compliance standards in Japan impacting the operations of preclinical CROs. |
4.3.2 High competition among preclinical CROs leading to pricing pressures and margin constraints. |
4.3.3 Limited availability of skilled workforce with expertise in preclinical research. |
5 Japan Preclinical CRO Market Trends |
6 Japan Preclinical CRO Market, By Types |
6.1 Japan Preclinical CRO Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Japan Preclinical CRO Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 Japan Preclinical CRO Market Revenues & Volume, By Bioanalysis and DMPK Studies, 2021- 2031F |
6.1.4 Japan Preclinical CRO Market Revenues & Volume, By Toxicology Testing, 2021- 2031F |
6.1.5 Japan Preclinical CRO Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Preclinical CRO Market, By End Use |
6.2.1 Overview and Analysis |
6.2.2 Japan Preclinical CRO Market Revenues & Volume, By Biopharmaceutical Companies, 2021- 2031F |
6.2.3 Japan Preclinical CRO Market Revenues & Volume, By Government and Academic Institutes, 2021- 2031F |
6.2.4 Japan Preclinical CRO Market Revenues & Volume, By Medical Device Companies, 2021- 2031F |
7 Japan Preclinical CRO Market Import-Export Trade Statistics |
7.1 Japan Preclinical CRO Market Export to Major Countries |
7.2 Japan Preclinical CRO Market Imports from Major Countries |
8 Japan Preclinical CRO Market Key Performance Indicators |
8.1 Percentage of new drug candidates outsourced to preclinical CROs. |
8.2 Number of collaborations between pharmaceutical/biotech companies and preclinical CROs. |
8.3 Average time taken for preclinical research and development projects to progress from one phase to another. |
8.4 Percentage of projects completed within the specified timelines. |
8.5 Client satisfaction scores based on project delivery and quality of services provided. |
9 Japan Preclinical CRO Market - Opportunity Assessment |
9.1 Japan Preclinical CRO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 Japan Preclinical CRO Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Japan Preclinical CRO Market - Competitive Landscape |
10.1 Japan Preclinical CRO Market Revenue Share, By Companies, 2024 |
10.2 Japan Preclinical CRO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |